Inogen (INGN) Capital Expenditures (QoQ) (2013 - 2026)
Inogen (INGN) Capital Expenditures (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.04% |
| Mar 31, 2026 | 23.64% |
| Dec 31, 2025 | -830.10% |
| Sep 30, 2025 | -402.94% |
| Jun 30, 2025 | -76.71% |
| Mar 31, 2025 | 110.30% |
| Dec 31, 2024 | -269.60% |
| Sep 30, 2024 | 32.62% |
| Jun 30, 2024 | 1,160.00% |
| Mar 31, 2024 | 133.78% |
| Dec 31, 2023 | -119.77% |
| Sep 30, 2023 | 3,502.27% |
| Jun 30, 2023 | 6.38% |
| Mar 31, 2023 | 47.19% |
| Dec 31, 2022 | 96.25% |
| Sep 30, 2022 | -372.53% |
| Jun 30, 2022 | -36.31% |
| Mar 31, 2022 | 418.41% |
| Dec 31, 2021 | -206.98% |
| Sep 30, 2021 | 1,585.19% |